ITCI 250117 35.00C (ITCI250117C35000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ITCI250117C35000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 24 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

J&J Beats in Q4 With in Line Guidance; so Why Is Its Stock Falling?
Seeking AlphaJan 22 11:04 ET
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Barron'sJan 22 10:47 ET
Intra-Cellular Ticks Higher as J&J Forecasts Early Q2 Close
Seeking AlphaJan 22 10:30 ET
Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
BenzingaJan 22 08:21 ET
RBC Capital Downgrades Intra-Cellular Therapies(ITCI.US) to Hold Rating, Raises Target Price to $132
Moomoo NewsJan 22 07:34 ET · Ratings
RBC Downgrades Intra-Cellular Therapies to Sector Perform From Outperform on Proposed Sale to Johnson & Johnson
MT NewswiresJan 22 06:35 ET

Comments

Meta Moo

Jan 17 12:53

Columns Johnson & Johnson Sees Possible Bullish Chart Ahead of Earnings

$Johnson & Johnson (JNJ.US)$ will report Q4 numbers next Wednesday (Jan. 22) at a time when the medical company’s stock has been under the weather, falling back some 14% since early September even as the S&P 500 gained about 7%. What does JNJ's technical and fundamental analysis say could happen from here?
Let's look:
Johnson & Johnson's Fundamental Analysis
The Street is looking for JNJ to report $2.04 in adjusted Q4 earnings per sha...

Kevin Travers

Jan 13 15:07

Columns Wall Street Today: Market Turns Around, Let's See if it Lasts

Overall, the market pulled a fast one on traders on Monday. The S&P 500 started down but built into a climb by the end of the day.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.16%, the $Dow Jones Industrial Average (.DJI.US)$ was climbing 0.86%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 0.38%.
MACRO
In macroeconomic news this week, watch for Fed speakers, CPI inflation data on Wednesday, and Retail sale data on Thursday.
SECTORS
This week is the s...

Weekly Buzz

Kevin Travers

Jan 13 09:52

Columns Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season

Happy Monday, January 13th. The market began the week falling, but you'll never guess why: here's the Live Stock news.
$Moderna (MRNA.US)$ is falling 21% on Monday, the lowest percentage decliner on the S&P 500 after the firm updated its 2025 guidance, slashing its sales and revenue guidance by $1B, from a range of $2.5-$3.5B it gave in Sept.
$Micron Technology (MU.US)$ was one of the largest percentage ...

Live Stock Financial Podcast. What are you watching on the market?

103418136

Jan 13 08:35

$Intra-Cellular Therapies (ITCI.US)$ am i buy too high at $125?

Movers and Shakers

Jan 13 07:45

Columns Today's Pre-Market Movers and Top Ratings | ANF, LULU, ITCI and More

Morning Movers
Gapping up
$Lululemon Athletica (LULU.US)$ shares climbed 3.9% after the company raised its current-quarter targets, driven by strong holiday-season demand for its apparel.
$Enfusion (ENFN.US)$ shares surged 12% after Clearwater Analytics (NYSE:CWAN), which rose 1.7%, announced a $1.5 billion cash-and-stock acquisition of the investment management platform.
$Intra-Cellular Therapies (ITCI.US)$ shares skyrocketed 35% ...